Rafael Holdings Inc
RFL1.240USD
0.000
Close 12/19, 16:00（ET）Quotes delayed by 15 min
64.87MMarket Cap
LossP/E TTM
More Details of Rafael Holdings Inc Company
Rafael Holdings, Inc. is a biotechnology company. The Company holds interests in clinical and early-stage pharmaceutical companies, including a 100% interest in Cyclo Therapeutics, LLC, a biotechnology company focusing on developing its lead clinical candidate, Trappsol Cyclo, which is being evaluated in clinical trials, including an ongoing Phase III trial for the potential treatment of Niemann-Pick Disease Type C1 (NPC1), a rare, fatal, and progressive genetic disorder. It also holds an interest in LipoMedix Pharmaceuticals Ltd., a clinical-stage pharmaceutical company; Barer Institute Inc., a wholly owned preclinical cancer metabolism research operation, and an interest in Cornerstone Pharmaceuticals, Inc., a cancer metabolism-based therapeutics company. It holds an interest in Rafael Medical Devices, LLC, an orthopedic-focused medical device company developing instruments to advance minimally invasive surgeries, and a majority interest in Day Three Labs, Inc.
Rafael Holdings Inc Info
Ticker SymbolRFL
Company nameRafael Holdings Inc
IPO dateMar 12, 2018
CEOJonas (Howard S)
Number of employees21
Security typeOrdinary Share
Fiscal year-endMar 12
Address520 Broad Street
CityNEWARK
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code07120
Phone12126581450
Websitehttps://rafaelholdings.com
Ticker SymbolRFL
IPO dateMar 12, 2018
CEOJonas (Howard S)
Company Executives of Rafael Holdings Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Howard S. Jonas
Mr. Howard S. Jonas
Executive Chairman of the Board, President, Chief Executive Officer
Executive Chairman of the Board, President, Chief Executive Officer
14.01M
+0.85%
Dr. Michael J. Weiss, M.D., Ph.D.
Dr. Michael J. Weiss, M.D., Ph.D.
Independent Director
Independent Director
102.49K
+0.01%
Mr. N. Scott Fine
Mr. N. Scott Fine
Non-Executive Vice Chairman of the Board
Non-Executive Vice Chairman of the Board
--
--
Mr. Joshua M. Fine
Mr. Joshua M. Fine
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Alan Grayson
Mr. Alan Grayson
Independent Director
Independent Director
--
--
Mr. Mark N. Stein, M.D.
Mr. Mark N. Stein, M.D.
Independent Director
Independent Director
--
--
Mr. Markus Walter Sieger
Mr. Markus Walter Sieger
Lead Independent Director
Lead Independent Director
--
--
Mr. David A. Polinsky
Mr. David A. Polinsky
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Susan Bernstein
Ms. Susan Bernstein
Director
Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Howard S. Jonas
Mr. Howard S. Jonas
Executive Chairman of the Board, President, Chief Executive Officer
Executive Chairman of the Board, President, Chief Executive Officer
14.01M
+0.85%
Dr. Michael J. Weiss, M.D., Ph.D.
Dr. Michael J. Weiss, M.D., Ph.D.
Independent Director
Independent Director
102.49K
+0.01%
Mr. N. Scott Fine
Mr. N. Scott Fine
Non-Executive Vice Chairman of the Board
Non-Executive Vice Chairman of the Board
--
--
Mr. Joshua M. Fine
Mr. Joshua M. Fine
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Alan Grayson
Mr. Alan Grayson
Independent Director
Independent Director
--
--
Mr. Mark N. Stein, M.D.
Mr. Mark N. Stein, M.D.
Independent Director
Independent Director
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Thu, Nov 20
Updated: Thu, Nov 20
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Jonas (Howard S)
27.47%
i9 PLUS, L.L.C.
7.09%
The Vanguard Group, Inc.
2.74%
Conkling (William)
0.96%
IEQ Capital LLC
0.83%
Other
60.91%
Shareholders
Shareholders
Proportion
Jonas (Howard S)
27.47%
i9 PLUS, L.L.C.
7.09%
The Vanguard Group, Inc.
2.74%
Conkling (William)
0.96%
IEQ Capital LLC
0.83%
Other
60.91%
Shareholder Types
Shareholders
Proportion
Individual Investor
30.51%
Corporation
7.09%
Investment Advisor
4.25%
Investment Advisor/Hedge Fund
1.58%
Family Office
0.83%
Venture Capital
0.50%
Research Firm
0.46%
Hedge Fund
0.33%
Other
54.46%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
90
3.64M
7.15%
-222.66K
2025Q2
93
21.63M
63.05%
+13.10M
2025Q1
98
8.17M
28.85%
-61.05K
2024Q4
90
7.29M
30.39%
-660.45K
2024Q3
94
7.39M
31.07%
-354.11K
2024Q2
109
7.56M
31.85%
-1.78M
2024Q1
142
7.38M
31.10%
-2.82M
2023Q4
152
7.68M
32.41%
-2.73M
2023Q3
187
7.52M
31.90%
-4.47M
2023Q2
197
7.66M
32.47%
-4.19M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Jonas (Howard S)
13.89M
40.5%
-9.90K
-0.07%
Sep 13, 2025
i9 PLUS, L.L.C.
3.62M
10.54%
+390.63K
+12.11%
Jun 05, 2025
The Vanguard Group, Inc.
1.26M
3.68%
+258.36K
+25.75%
Jun 30, 2025
Conkling (William)
564.46K
1.65%
+12.64K
+2.29%
Mar 25, 2025
IEQ Capital LLC
224.03K
0.65%
-14.85K
-6.21%
Jun 30, 2025
Geode Capital Management, L.L.C.
451.14K
1.32%
+190.18K
+72.88%
Jun 30, 2025
Fine (Nathan Scott)
335.35K
0.98%
+335.35K
--
Jul 14, 2025
BlackRock Institutional Trust Company, N.A.
383.35K
1.12%
+165.56K
+76.02%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
337.13K
0.98%
-1.30K
-0.38%
Jun 30, 2025
Polinsky (David)
264.82K
0.77%
-3.25K
-1.21%
Sep 23, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
iShares Micro-Cap ETF
0%
Dimensional US Core Equity 1 ETF
0%
Avantis US Small Cap Equity ETF
0%
iShares Micro-Cap ETF
Proportion0%
Dimensional US Core Equity 1 ETF
Proportion0%
Avantis US Small Cap Equity ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Rafael Holdings Inc?
The top five shareholders of Rafael Holdings Inc are:
Jonas (Howard S) holds 13.89M shares, accounting for 40.50% of the total shares.
i9 PLUS, L.L.C. holds 3.62M shares, accounting for 10.54% of the total shares.
The Vanguard Group, Inc. holds 1.26M shares, accounting for 3.68% of the total shares.
Conkling (William) holds 564.46K shares, accounting for 1.65% of the total shares.
IEQ Capital LLC holds 224.03K shares, accounting for 0.65% of the total shares.
Jonas (Howard S) holds 13.89M shares, accounting for 40.50% of the total shares.
i9 PLUS, L.L.C. holds 3.62M shares, accounting for 10.54% of the total shares.
The Vanguard Group, Inc. holds 1.26M shares, accounting for 3.68% of the total shares.
Conkling (William) holds 564.46K shares, accounting for 1.65% of the total shares.
IEQ Capital LLC holds 224.03K shares, accounting for 0.65% of the total shares.
What are the top three shareholder types of Rafael Holdings Inc?
The top three shareholder types of Rafael Holdings Inc are:
Jonas (Howard S)
i9 PLUS, L.L.C.
The Vanguard Group, Inc.
Jonas (Howard S)
i9 PLUS, L.L.C.
The Vanguard Group, Inc.
How many institutions hold shares of Rafael Holdings Inc (RFL)?
As of 2025Q3, 90 institutions hold shares of Rafael Holdings Inc, with a combined market value of approximately 3.64M, accounting for 7.15% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -55.90%.
What is the biggest source of revenue for Rafael Holdings Inc?
In --, the -- business generated the highest revenue for Rafael Holdings Inc, amounting to -- and accounting for --% of total revenue.
